External RNA Control Consortium Workshop:
Specifications for Universal External RNA Spike-In Controls


National Institute of Standards and Technology
Gaithersburg, MD, USA
Building 101, Green Auditorium
December 2, 2003

-- TALKS ARE ACCESSIBLE FROM THE AGENDA HYPERLINKS --
(May Require Adobe Reader 6.0)

Acrobat Reader Icon

Workshop Background

Workshop Objectives

Agenda
(Access to Talks)

Draft Specification Document (Requires Adobe Reader 6.0)

Acrobat Reader Icon

Hotels and Travel

 

Background
The External RNA Controls Consortium (ERCC) is composed of representatives from the public, private, and academic sectors, working together to produce external RNA spike-in controls that will be useful for sample control on a variety of microarray platforms and by RT-PCR. These platform-independent control materials are needed for performance evaluation of reproducibility, sensitivity, and robustness in gene expression analysis.

Development of these controls is consistent with recommendations made at the March 2003 NIST-Stanford meeting, Metrology and Standards Needs for Gene Expression Technologies: Universal RNA Standards. The ERCC will also produce recommended protocols for the use of the controls. The ERCC intends for these materials to have ready access and broad acceptance within the research and clinical communities. The controls shall consist of 100 well characterized clones comprised of random unique sequence as determined by sequence comparison to mouse, rat, human, drosophila, E. coli, mosquito sequence databases, as well as well characterized Bacillus subtillus and Arabadopsis thaliana clones.


Workshop Objectives
The External RNA Controls Consortium (ERCC) has collaboratively developed a specification for external RNA spike-in controls that can be used to characterize the performance of a gene-expression measurement. This specification is presented for review and comment, and NIST is hosting a workshop intended to provide a forum for interactive discussion of the specification and planning for its continued development and implementation.

Workshop Agenda

Registration, coffee

8:00 AM

Welcome

8:30

Introduction/History/Charge to the workshop

8:40

FDA perspective

9:10

Interactive document review

 

Access and Usability Requirements

9:30

Product Description, Characteristics

9:50

Proposed Kit Configurations, Shelf life, Storage

10:10

Coffee Break

10:30

Characteristics of Product Kits

11:00

Protocols

11:20

Testing

11:40

Lunch

12:00 PM

Definitions and Assumptions for Measuring Acceptable Performance

1:30

External RNA Control Quality Control by Quantitative
Reverse Transcription-Polymerase Chain Reaction (RT-PCR)

1:50

Comparison of External RNA Controls on
Different Technology Platforms, Microarray and RT-PCR

2:10

Coffee Break

2:30

Panel Discussion – Technical Challenges and Gaps

3:00

Interactive session: workplan and production specification development, resource requirements

3:45

Workshop Summary and Next steps

4:30

Workshop concludes

5:00

Sponsors and Endorsements:

NIST Biotechnology Division
Biotechnology Division (NIST Chemical Science and Technology Laboratory)

Workshop Organizers:

Marc Salit

Research Chemist
Chemical Science and Technology Laboratory
National Institute of Standards and Technology
Marc.Salit@nist.gov

Janet A. Warrington

Vice President
Clinical and Applied Genomic Research & Development
Affymetrix, Inc.
Janet_Warrington@affymetrix.com

Questions or Problems
Created: 10/29/2003
Updated: 12/12/2003
NIST
Disclaimer/Privacy Statement